Brune, Daniela
Stojanov, Thomas
Müller, Andreas Marc
Weibel, David
Hunziker, Sabina
Erdbrink, Stephanie
,
Rosso, Claudio
Akgün, Doruk
Weiss, Isabella
Samaniego, Eduardo
Suter, Thomas
Müller, Sebastian A
Saner, Markus
Haag-Schumacher, Claudia
Dao Trong, Mai Lan
Buitrago-Tellez, Carlos
Hasler, Julian
Riede, Ulf
Moor, Beat
Biner, Matthias
Gallusser, Nicolas
Spormann, Christoph
Hansen, Britta
Durchholz, Holger
Cunningham, Gregory
Lädermann, Alexandre
Schä, Michael
Egli, Rainer
Gerber, Kate
Lombardo, Paolo
Weihs, Johannes
Flury, Matthias
Berther, Ralph
Ehrmann, Christine
Hübscher, Larissa
Schwappach, David
Eid, Karim
Bensler, Susanne
Fritz, Yannick
Benninger, Emanuel
Grimm, Philemon
Pisan, Markus
Scheibel, Markus
Jong, Marije de
Diermayr, Stefan
Etter, Marco
Freislederer, Florian
Glanzmann, Michael
Grobet, Cécile
Jung, Christian
Moro, Fabrizio
Ringer, Ralph
Schätz, Jan
Schwyzer, Hans-Kaspar
Wehrli, Martina
Wirth, Barbara
Candrian, Christian
Del Grande, Filippo
Feltri, Pietro
Filardo, Giuseppe
Marbach, Francesco
Schönweger, Florian
Jost, Bernhard
Badulescu, Michael
Lüscher, Stephanie
Napieralski, Fabian
Öhrström, Lena
Olach, Martin
Rechsteiner, Jan
Scheler, Jörg
Spross, Christian
Zdravkovic, Vilijam
Zumstein, Matthias A
Hayoz, Annabel
Müller-Lebschi, Julia
Wieser, Karl
Borbas, Paul
Bouaicha, Samy
Camenzind, Roland
Catanzaro, Sabrina
Gerber, Christian
Grubhofer, Florian
Hasler, Anita
Hochreiter, Bettina
Marcus, Roy
Selman, Farah
Sutter, Reto
Wyss, Sabine
Appenzeller-Herzog, Christian
Aghlmandi, Soheila
Baum, Cornelia
Eckers, Franziska
Grezda, Kushtrim
Hatz, Simone
Taha, Mohy
Tamborrini-Schütz, Giorgio
Audigé, Laurent
Article History
Received: 8 March 2024
Accepted: 19 November 2024
First Online: 4 December 2024
Declarations
:
: This project was carried out in accordance with the protocol and principles enunciated in the current version of the Declaration of Helsinki and guidelines of Good Clinical Practice (GCP) issued by the International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) as well as Swiss law and Swiss regulatory authority requirements. Ethics approval was obtained on April 1st, 2020 from the lead ethics committee (Ethikkommission Nordwest- und Zentralschweiz (EKNZ), Basel, Switzerland; ID: 2019-02076) followed by subsequent amendments until December 20th, 2022, associated with the implementation of additional MRI examinations.All participants provided informed written consent before study enrollment .
: Not applicable.
: The authors declare no competing interests.